Trump nominates Marty Makary, who opposed COVID ...
President-elect Donald Trump has nominated a critic of COVID-19 health measures to lead the Food and Drug Administration.
www.cbsnews.comHere’s the latest I can share about Marty Makary based on recent reporting.
-
FDA leadership reference: In late 2024, President Trump nominated Dr. Marty Makary to head the FDA, signaling a push for regulatory reform and higher emphasis on scientific review, though his confirmation and tenure were subject to Senate approval and subsequent developments. This indicates a shift in FDA leadership aspirations around that period, with Makary aiming to influence drug and device regulation.[1]
-
Public positions during the pandemic: Makary gained prominence as a critic of certain COVID-19 public health measures, including vaccine mandates, while expressing support for vaccines for adults and urging caution around some policy moves; his stance drew both support and criticism from peers and observers. His public commentary during the pandemic remains a defining aspect of how he’s viewed by the medical community and policymakers.[2][1]
-
Confirmation and role context: Coverage in early 2025 highlighted that Makary appeared at a Senate HELP Committee hearing as part of the confirmation process, with reporting noting that his nomination faced a partisan Senate path and would require cross-party support to advance. Analysts framed him as a surgeon-policy thinker who would need to balance science, regulation, and industry interests if confirmed.[3]
If you’d like, I can pull up the most current updates from major outlets (e.g., major newspapers or health policy outlets) and summarize any new developments, including confirmation status, tenure, or shifts in FDA policy under Makary.